FDA Approves Cordis Vascular Closure Device for Cardiac Ablation Procedures

The approval of the Mynx Control venous vascular closure device is based on the results of the ReliaSeal trial, which demonstrated a 100% procedure and device success rate in cardiac ablation procedures.